Regulatory Affairs Archives

28 Jun 22

Pharmaceutical Promotion: UMAO & related laws and regulations

To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the public via different mediums, the HKAPI organises an event with law enforcement authorities and experts to explain the law and its enforcement.

02 Jun 22

Tackling the Threat of Antimicrobial Resistance

The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.

25 Mar 22

Regulatory Training Workshop Series concluded successfully

The Regulatory Training Workshop Series held from February to March 2022 concluded successfully.

14 Jan 22

Webinar – Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong

Dr Daniel Lee of the Chinese University of Hong Kong, introduced the first ATP GMP facility in Hong Kong to our members.

January 14, 2021
HKAPI
No Comments

The Greater Bay Area development has taken centre stage in Hong Kong Policy Address 2020. To facilitate members taking business opportunities in GBA, HKAPI jointly organized a virtual training with the Shenzhen Hospital Manager Association in November and December 2020.

December 18, 2019
HKAPI
No Comments

On December 18, 2019, around 70 members from the regulatory affairs and pharmacovigilance department attended the New Product submission and Best Practice Workshop held at HKU.

October 17, 2019
HKAPI
No Comments

About 60 members, non-members and academics turned up for Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop jointly organized by The University of Hong Kong and HKAPI.

14 Dec 18

Drug Office-HKAPI Joint Briefing Session

On 14 December 2018, a joint briefing session between the Drug Office and HKAPI was held at the Public Health Laboratory Centre in Kowloon. It was overwhelmingly attended by about 90 members, with the majority being Regulatory Affairs staff.

09 Jan 18

Regulatory Training Programme Course 4 (Pharmacovigilance)

85 members, non-members and academics turned up for Regulatory Training Programme Course 4 – the last core course of the Programme which is jointly organized by The University of Hong Kong and HKAPI.

Pharmaceutical Promotion: UMAO & related laws and regulations

Tackling the Threat of Antimicrobial Resistance

Regulatory Training Workshop Series concluded successfully

Webinar – Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong

GBA Training 2020

New Product Submission and Best Practice Workshop

Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop

Drug Office-HKAPI Joint Briefing Session

Regulatory Training Programme Course 4 (Pharmacovigilance)

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use